Neurohumoral Effects of the New Orally Active Renin Inhibitor, Aliskiren, in Chronic Heart Failure

Abstract

Aliskiren appeared to suppress the RAAS as effectively as ramipril in the short term. RIs may offer an alternative therapeutic approach to the blockade of the RAAS.